Search research articles
Contact Us
Filters
Showing results (41-50 of 304) with videos related to
Page
of 31
Sort By:
International Journal of Cancer
|
June 28, 2005
B7-1 and B7-2 act differentially in the induction of a T cell response: their impact for a HLA-matched and HLA-mismatched anti-tumor immunotherapy
Kai Kronfeld, Hinrich Abken, Barbara Seliger
Trends in Molecular Medicine
|
November 29, 2011
The immunomodulatory capacity of mesenchymal stem cells
Antje Gebler, Olivia Zabel, Barbara Seliger
Journal for Immunotherapy of Cancer
|
August 29, 2024
Immune modulatory microRNAs in tumors, their clinical relevance in diagnosis and therapy
Christoforos Vaxevanis, Michael Bachmann, Barbara Seliger
Biochimica Et Biophysica Acta
|
November 26, 2013
Towards defining biomarkers indicating resistances to targeted therapies
Franziska Stehle, Kristin Schulz, Barbara Seliger
Contributions to Nephrology
|
May 25, 2005
Heat shock proteins in renal cell carcinomas
Derek Atkins, Rudolf Lichtenfels, Barbara Seliger
International Journal of Cancer
|
July 9, 2005
Molecular mechanisms of HLA class I antigen abnormalities following viral infection and transformation
Barbara Seliger, Ulrike Ritz, Soldano Ferrone
Seminars in Cancer Biology
|
April 3, 2012
The role of classical and non-classical HLA class I antigens in human tumors
Juergen Bukur, Simon Jasinski, Barbara Seliger
Trends in Immunology
|
January 28, 2003
HLA-G and MIC expression in tumors and their role in anti-tumor immunity
Barbara Seliger, Hinrich Abken, Soldano Ferrone
Journal of the National Cancer Institute
|
September 14, 2014
The role of microRNAs in the control of innate immune response in cancer
Simon Jasinski-Bergner, Ofer Mandelboim, Barbara Seliger
International Journal of Molecular Sciences
|
July 29, 2020
The Role of the RNA-Binding Protein Family MEX-3 in Tumorigenesis
Simon Jasinski-Bergner, André Steven, Barbara Seliger
Page
of 31
Search research articles
Search
Showing results (41-50 of 304) with videos related to
Sort By:
Page
of 31
International Journal of Cancer
|
June 28, 2005
B7-1 and B7-2 act differentially in the induction of a T cell response: their impact for a HLA-matched and HLA-mismatched anti-tumor immunotherapy
Kai Kronfeld, Hinrich Abken, Barbara Seliger
Trends in Molecular Medicine
|
November 29, 2011
The immunomodulatory capacity of mesenchymal stem cells
Antje Gebler, Olivia Zabel, Barbara Seliger
Journal for Immunotherapy of Cancer
|
August 29, 2024
Immune modulatory microRNAs in tumors, their clinical relevance in diagnosis and therapy
Christoforos Vaxevanis, Michael Bachmann, Barbara Seliger
Biochimica Et Biophysica Acta
|
November 26, 2013
Towards defining biomarkers indicating resistances to targeted therapies
Franziska Stehle, Kristin Schulz, Barbara Seliger
Contributions to Nephrology
|
May 25, 2005
Heat shock proteins in renal cell carcinomas
Derek Atkins, Rudolf Lichtenfels, Barbara Seliger
International Journal of Cancer
|
July 9, 2005
Molecular mechanisms of HLA class I antigen abnormalities following viral infection and transformation
Barbara Seliger, Ulrike Ritz, Soldano Ferrone
Seminars in Cancer Biology
|
April 3, 2012
The role of classical and non-classical HLA class I antigens in human tumors
Juergen Bukur, Simon Jasinski, Barbara Seliger
Trends in Immunology
|
January 28, 2003
HLA-G and MIC expression in tumors and their role in anti-tumor immunity
Barbara Seliger, Hinrich Abken, Soldano Ferrone
Journal of the National Cancer Institute
|
September 14, 2014
The role of microRNAs in the control of innate immune response in cancer
Simon Jasinski-Bergner, Ofer Mandelboim, Barbara Seliger
International Journal of Molecular Sciences
|
July 29, 2020
The Role of the RNA-Binding Protein Family MEX-3 in Tumorigenesis
Simon Jasinski-Bergner, André Steven, Barbara Seliger
Page
of 31